Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
22nd week of 2021 patent applcation highlights part 10
Patent application number
Title
Published
20210161964
METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF
2021-06-03
20210161965
KIR3DL1/HLA-B SUBTYPES FOR HEMATOPOIETIC CELL TRANSPLANTATION DONOR SELECTION
2021-06-03
20210161966
METHODS OF TREATING LYSOSOMAL DISORDERS
2021-06-03
20210161967
EXTRACELLULAR VESICLES AND USES THEREOF
2021-06-03
20210161968
USE OF MICRONEEDLE PATCH TO PROMOTE HAIR GROWTH
2021-06-03
20210161969
COMPOSITION COMPRISING EXOSOME AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF ACUTE LIVER FAILURE
2021-06-03
20210161970
METHODS AND USES OF BIOLOGICAL TISSUES FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONS
2021-06-03
20210161971
ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION
2021-06-03
20210161972
TOPICAL COMPOSITION COMPRISED OF COD LI VER OIL FOR TREATING WOUNDS AND SKIN DISORDERS
2021-06-03
20210161973
AQUEOUS EXTRACT OF GROUND MATERIAL OF PLANARIAN ORGANISMS
2021-06-03
20210161974
MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT
2021-06-03
20210161975
INACTIVATED BACILLUS COAGULANTS AND USES THEREOF FOR REDUCING STRESS
2021-06-03
20210161976
BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
2021-06-03
20210161977
NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-1 AND USE THEREOF IN INHIBITING STREPTOCOCCUS SUIS BACTERIUM PROLIFERATION
2021-06-03
20210161978
NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-3, AND USE THEREOF FOR INHIBITING PROLIFERATION OF STREPTOCOCCUS SUIS STRAINS
2021-06-03
20210161979
CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
2021-06-03
20210161980
SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT
2021-06-03
20210161981
Methods for Liberating Phosphorus from Organic Matter
2021-06-03
20210161982
PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR ISCHEMIA TREATMENT
2021-06-03
20210161983
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF
2021-06-03
20210161984
Vaporized Medicants and Methods of Use
2021-06-03
20210161986
CAFFEINE COMPOSITIONS AND METHODS OF USE
2021-06-03
20210161987
WATER-IN-OIL NANO-EMULSION OF SAFFRON AND A METHOD OF PREPARING THEREOF
2021-06-03
20210161988
Composition for Treating Diarrhea
2021-06-03
20210161989
APPARATUS AND METHOD FOR PROCESSING ORGANIC BAMBOO LEAF EXTRACT PRODUCTS
2021-06-03
20210161990
STABLE DRY PROBIOTIC COMPOSITIONS FOR SPECIAL DIETARY USES
2021-06-03
20210161991
USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
2021-06-03
20210161992
PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF
2021-06-03
20210161993
Method for accelerated healing of burn wounds
2021-06-03
20210161994
IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
2021-06-03
20210161995
TERLIPRESSIN COMPOSITIONS AND USES THEREOF
2021-06-03
20210161996
Granular Pharmaceutical Composition
2021-06-03
20210161997
TREATING DISEASES VIA TARGETED MODULATION OF GENE SIGNALING NETWORKS
2021-06-03
20210161998
COMPOSITION FOR CELL PROTECTION CONTAINING CYCLO HISTIDINE-PROLINE AS ACTIVE INGREDIENT
2021-06-03
20210161999
COMPOSITIONS AND METHODS RELATED TO OVERCOMING INNATE IMMUNE BARRIERS TO CANCER IMMUNOTHERAPY
2021-06-03
20210162000
PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
2021-06-03
20210162001
PLANTARICIN NC8 ALPHA BETA MARKEDLY ENHANCES THE EFFECTS OF ANTIBIOTICS
2021-06-03
20210162002
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS
2021-06-03
20210162003
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE
2021-06-03
20210162004
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
2021-06-03
20210162005
Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide
2021-06-03
20210162006
Use of CD24 Proteins for Treating Leptin-Deficient Conditions
2021-06-03
20210162007
MODULATING NUCLEAR RECEPTORS AND METHODS OF USING SAME
2021-06-03
20210162008
TISSUE REPAIR
2021-06-03
20210162010
TARGETED HUMAN-INTERFERON FUSION PROTEINS
2021-06-03
20210162011
Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
2021-06-03
20210162012
COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF
2021-06-03
20210162013
COMPOSITIONS AND METHODS FOR IMPROVING THE BIOAVAILABILITY OF GLP1 AND ANALOGUES THEREOF
2021-06-03
20210162014
ENCAPSULATION OF ULTRA-STABLE INSULIN ANALOGUES WITH POLYMER MELTS
2021-06-03
20210162015
TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS
2021-06-03
20210162016
METHOD OF DELIVERING A SOMATOSTATIN COMPOUND INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
2021-06-03
20210162017
DIRECTED STEM CELL RECRUITMENT
2021-06-03
20210162018
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PRETERM BIRTH
2021-06-03
20210162019
IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS
2021-06-03
20210162020
SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM)
2021-06-03
20210162021
MARKER FOR ACID SPHINGOMYELINASE DISORDERS AND USES THEREOF
2021-06-03
20210162022
SEQUENCE SPECIFIC ANTIMICROBIALS
2021-06-03
20210162023
METHODS OF TREATING NEUROFIBROMATOSIS TYPE 1 AND RELATED CONDITIONS WITH ALKALINE PHOSPHATASE
2021-06-03
20210162024
METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
2021-06-03
20210162025
VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE
2021-06-03
20210162026
TRANSMUCOSAL BOTULINUM TOXIN COMPOSITIONS, KITS, AND METHODS FOR TREATING BLADDER DISORDERS
2021-06-03
20210162027
BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN
2021-06-03
20210162028
Methods for Inducing Intermittent Fasting and Modulating Autophagy
2021-06-03
20210162029
COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN DISEASES AND DISORDERS WITH LEKTI
2021-06-03
20210162030
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH LEKTI
2021-06-03
20210162031
METHODS AND COMPOSITIONS FOR TREATING CANCERS
2021-06-03
20210162032
CANCER VACCINES FOR BREAST CANCER
2021-06-03
20210162033
BURKHOLDERIA PSEUDOMALLEI COMPLEX OUTER MEMBRANE VESICLES AS ADJUVANTS
2021-06-03
20210162034
MDR E. COLI SPECIFIC ANTIBODY
2021-06-03
20210162035
Zika Vaccines and Methods of Use
2021-06-03
20210162036
IMPROVED DILUENT FOR CELL-ASSOCIATED ALPHAHERPESVIRUS VACCINE
2021-06-03
20210162037
INFLUENZA MRNA VACCINES
2021-06-03
20210162038
PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
2021-06-03
20210162039
MULTIEPITOPE FUSION ANTIGENS FOR VACCINATION AND METHODS OF MAKING AND USING SUCH ANTIGENS
2021-06-03
20210162040
TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUS
2021-06-03
20210162041
HELPER EPITOPE PEPTIDE AND APPLICATION THEREOF
2021-06-03
20210162042
NOVEL METHODS FOR MANUFACTURING AN ADJUVANT
2021-06-03
20210162043
TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA
2021-06-03
20210162044
METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS
2021-06-03
20210162045
HUMAN ENDOTHELIN RECEPTOR ANTIBODY AND USE THEREOF
2021-06-03
20210162046
EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
2021-06-03
20210162047
A Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It.
2021-06-03
20210162048
Photoswitchable HDAC Inhibitors
2021-06-03
20210162049
RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS
2021-06-03
20210162050
TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT
2021-06-03
20210162051
AQUEOUS-BASED COMPOSITIONS
2021-06-03
20210162052
Compositions for Transfecting Resistant Cell Types
2021-06-03
20210162053
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
2021-06-03
20210162054
HYDRAZINYL-INDOLE COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE
2021-06-03
20210162055
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
2021-06-03
20210162056
TARGETING MACULA DENSA CELLS AS A NEW THERAPEUTIC APPROACH FOR KIDNEY DISEASE
2021-06-03
20210162057
CONJUGATES AND METHODS OF USING THE SAME
2021-06-03
20210162058
ENGINEERED POLYPEPTIDE CONJUGATES USING TRANSGLUTAMINASE
2021-06-03
20210162059
Human Antibodies to S. Aureus Hemolysin A Toxin
2021-06-03
20210162060
BIO-ORTHOGONAL DRUG ACTIVATION
2021-06-03
20210162061
IMMUNOCONJUGATES COMPRISING SIGNAL REGULATORY PROTEIN ALPHA
2021-06-03
20210162062
ANTIBODY-DRUG CONJUGATES TARGETING uPARAP
2021-06-03
20210162063
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
2021-06-03
20210162064
Nucleic Acid Carriers And Therapeutic Methods Of Use
2021-06-03
20210162065
MULTI-FUNCTIONAL CANCER DRUG DELIVERY NANODEVICE FOR PRECISION MEDICINE
2021-06-03